Livio Pagano

Medicine & Life Sciences

1. Hematologic Neoplasms 100%
2. Hematology 50%
3. Acute Myeloid Leukemia 48%
4. SARS Virus 46%
5. Multicenter Studies 42%
6. Mycoses 33%
7. CPX-351 32%
8. Italy 29%
9. Infections 29%
10. Mortality 27%
11. Compassionate Use Trials 25%
12. Invasive Fungal Infections 25%
13. Aspergillosis 24%
14. Allogeneic Cells 24%
15. Stem Cell Transplantation 23%
16. Cohort Studies 19%
17. Therapeutics 18%
18. Antibody Formation 18%
19. Central Nervous System Fungal Infections 18%
20. Seroconversion 17%
21. posaconazole 14%
22. Plasma Cell Neoplasms 14%
23. hydroxyethyl methacrylate 13%
24. Voriconazole 12%
25. Epidemiologic Studies 12%
26. Survival 11%
27. Prospective Studies 11%
28. Drug Therapy 11%
29. Paranasal Sinuses 11%
30. Neoplasms 11%
31. midostaurin 11%
32. Fusariosis 11%
33. Leukemia 11%
34. Fungemia 10%
35. Candidemia 10%
36. Bronchoalveolar Lavage 9%
37. Aspergillus 9%
38. Thyroid Gland 9%
39. Induction Chemotherapy 8%
40. Myelodysplastic Syndromes 8%
41. Incidence 7%
42. Retrospective Studies 7%
43. Recurrence 7%
44. B-Cell Chronic Lymphocytic Leukemia 7%
45. Bacterial Infections 7%
46. eltrombopag 6%
47. Azoles 6%
48. Invasive Pulmonary Aspergillosis 6%
49. Disease Management 6%
50. idelalisib 6%